Cypress Capital Management (Wyoming)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34K | Buy |
283
+25
| +10% | +$2.89K | 0.03% | 108 |
|
|
2025
Q4 | $27.4K | Buy |
258
+73
| +39% | +$6.85K | 0.03% | 104 |
|
|
2025
Q3 | $15.7K | Sell |
185
-150
| -45% | -$12.4K | 0.01% | 118 |
|
|
2025
Q2 | $26.8K | Hold |
335
| – | – | 0.03% | 104 |
|
|
2025
Q1 | $30.3K | Hold |
335
| – | – | 0.04% | 98 |
|
|
2024
Q4 | $33.6K | Hold |
335
| – | – | 0.04% | 89 |
|
|
2024
Q3 | $38K | Hold |
335
| – | – | 0.04% | 85 |
|
|
2024
Q2 | $41.7K | Hold |
335
| – | – | 0.04% | 82 |
|
|
2024
Q1 | $44.5K | Hold |
335
| – | – | 0.05% | 78 |
|
|
2023
Q4 | $36.8K | Hold |
335
| – | – | 0.04% | 84 |
|
|
2023
Q3 | $34.7K | Hold |
335
| – | – | 0.04% | 79 |
|
|
2023
Q2 | $38.9K | Hold |
335
| – | – | 0.04% | 74 |
|
|
2023
Q1 | $35.6K | Hold |
335
| – | – | 0.04% | 76 |
|
|
2022
Q4 | $37.4K | Hold |
335
| – | – | 0.05% | 78 |
|
|
2022
Q3 | $29K | Hold |
335
| – | – | 0.04% | 79 |
|
|
2022
Q2 | $31K | Hold |
335
| – | – | 0.04% | 83 |
|
|
2022
Q1 | $28K | Sell |
335
-150
| -31% | -$11.8K | 0.03% | 97 |
|
|
2021
Q4 | $38K | Hold |
485
| – | – | 0.03% | 135 |
|
|
2021
Q3 | $36K | Hold |
485
| – | – | 0.03% | 129 |
|
|
2021
Q2 | $38K | Sell |
485
-23
| -5% | -$1.71K | 0.03% | 153 |
|
|
2021
Q1 | $38K | Buy |
508
+89
| +21% | +$6.57K | 0.03% | 142 |
|
|
2020
Q4 | $33K | Buy |
419
+157
| +60% | +$12K | 0.03% | 132 |
|
|
2020
Q3 | $20K | Hold |
262
| – | – | 0.02% | 133 |
|
|
2020
Q2 | $19K | Hold |
262
| – | – | 0.02% | 136 |
|
|
2020
Q1 | $19K | Hold |
262
| – | – | 0.03% | 108 |
|
|
2019
Q4 | $23K | Hold |
262
| – | – | 0.02% | 122 |
|
|
2019
Q3 | $21K | Hold |
262
| – | – | 0.02% | 125 |
|
|
2019
Q2 | $21K | Sell |
262
-18,884
| -99% | -$1.45M | 0.03% | 155 |
|
|
2019
Q1 | $1.52M | Sell |
19,146
-350
| -2% | -$26.2K | 2.03% | 14 |
|
|
2018
Q4 | $1.42M | Buy |
19,496
+1,380
| +8% | +$97.4K | 2.73% | 7 |
|
|
2018
Q3 | $1.23M | Hold |
18,116
| – | – | 1.23% | 21 |
|
|
2018
Q2 | $1.05M | Sell |
18,116
-262
| -1% | -$14.8K | 1.1% | 26 |
|
|
2018
Q1 | $955K | Sell |
18,378
-1,189
| -6% | -$64.2K | 1.1% | 24 |
|
|
2017
Q4 | $1.06M | Sell |
19,567
-2,792
| -12% | -$155K | 1.2% | 20 |
|
|
2017
Q3 | $1.37M | Buy |
22,359
+105
| +0.5% | +$6.37K | 1.62% | 12 |
|
|
2017
Q2 | $1.36M | Hold |
22,254
| – | – | 1.56% | 14 |
|
|
2017
Q1 | $1.35M | Buy |
22,254
+471
| +2% | +$28.6K | 1.67% | 12 |
|
|
2016
Q4 | $1.25M | Buy |
21,783
+1,677
| +8% | +$98.1K | 1.31% | 17 |
|
|
2016
Q3 | $1.2M | Buy |
20,106
+105
| +0.5% | +$6.14K | 1.53% | 18 |
|
|
2016
Q2 | $1.1M | Buy |
20,001
+3,165
| +19% | +$168K | 1.44% | 18 |
|
|
2016
Q1 | $850K | Buy |
16,836
+891
| +6% | +$43.6K | 1.15% | 21 |
|
|
2015
Q4 | $804K | Hold |
15,945
| – | – | 1.01% | 24 |
|
|
2015
Q3 | $751K | Sell |
15,945
-881
| -5% | -$46.8K | 0.97% | 27 |
|
|
2015
Q2 | $914K | Buy |
16,826
+524
| +3% | +$29.4K | 1.03% | 27 |
|
|
2015
Q1 | $894K | Sell |
16,302
-2,096
| -11% | -$119K | 1.09% | 29 |
|
|
2014
Q4 | $997K | Buy |
+18,398
| New | +$1.03M | 1.29% | 24 |
|
Other funds holding MRK
VCM
VPM
Cypress Capital Management (Wyoming)'s MRK Position: Q1 2026 in Review
Cypress Capital Management (Wyoming) increased its Merck (MRK) stake by 9.7% in Q1 2026, buying an estimated $2.89K and bringing the position to 283 shares worth $34K. The position accounts for 0.03% of the portfolio, ranked #108.
Cypress Capital Management (Wyoming) first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.52M in Q1 2019. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Cypress Capital Management (Wyoming) held 283 shares of Merck worth $34K as of Q1 2026.
- Cypress Capital Management (Wyoming) bought 25 Merck shares in Q1 2026, an estimated $2.89K.
- Merck made up 0.03% of Cypress Capital Management (Wyoming)'s portfolio in Q1 2026, its #108 holding.
- Cypress Capital Management (Wyoming) first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- Cypress Capital Management (Wyoming)'s Merck position peaked at $1.52M in Q1 2019.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2026, filed 8 May 2026.